US equities
|
ANT
$97.17
▲+17.07%
NVDA
$145.98
▼-3.30%
AMD
$489.19
▼-7.72%
MU
$690.44
▼-2.10%
SPCX
$138.43
▼-3.53%
MSFT
$498.30
▼-1.97%
AAPL
$349.21
▼-0.92%
AMZN
$257.37
▼-3.87%
ANT
$97.17
▲+17.07%
NVDA
$145.98
▼-3.30%
AMD
$489.19
▼-7.72%
MU
$690.44
▼-2.10%
SPCX
$138.43
▼-3.53%
MSFT
$498.30
▼-1.97%
AAPL
$349.21
▼-0.92%
AMZN
$257.37
▼-3.87%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Quantum Biopharma Ltd. - Class B Subordinate Voting Shares
(NQ:
QNTM
)
1.420
-0.100 (-6.58%)
Delayed Quote
Updated: 4:00 PM EST, Nov 19, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Quantum Biopharma Ltd. - Class B Subordinate Voting Shares
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
Quantum Biopharma Announces that Sentinel Dosing has Started for the Phase-1 Multiple Ascending Dose Clinical Trial for Lucid-21-302 (Lucid-Ms) in Australia
October 29, 2024
Via
ACCESSWIRE
Quantum Biopharma (NASDAQ:QNTM) Posts Link on Its Website to Access the Filed Complaint Against CIBC World Markets, RBC Dominion Securities and Others, Seeking Damages in Excess of $700,000,000 USD, for Possible Stock Price Manipulation/Spoofing
October 22, 2024
Via
ACCESSWIRE
Quantum BioPharma Ltd. Alleges Market Manipulation, Files Lawsuit, unbuzzed Continues To Gain Traction
October 21, 2024
Quantum BioPharma Ltd. Alleges Market Manipulation, Files Lawsuit, unbuzzed Continues To Gain Traction
Via
News Direct
Topics
Lawsuit
Quantum BioPharma (Nasdaq: QNTM) Files a US Federal Lawsuit Against CIBC World Markets, RBC Dominion Securities and Others, Seeking Damages in Excess of $700,000,000 USD, for Possible Stock Price Manipulation/Spoofing
October 21, 2024
Via
ACCESSWIRE
Quantum BioPharma Ltd. (NASDAQ: QNTM): Pioneering Alcohol Metabolism Support with Unbuzzd
October 15, 2024
Via
AB Newswire
Quantum BioPharma Ltd. (NASDAQ: QNTM): Pioneering Alcohol Metabolism Support with Unbuzzd
October 15, 2024
Quantum BioPharma Ltd. (NASDAQ: QNTM): Pioneering Alcohol Metabolism Support with Unbuzzd
Via
News Direct
Quantum BioPharma Ltd. Pharma Provides Update from Celly Nutrition Signing a Master Distribution Agreement with FUSION Distribution Group Across Puerto Rico, the Caribbean, and Parts of Central and South America
October 07, 2024
Via
ACCESSWIRE
Quantum Biopharma Provides Corporate Update
September 27, 2024
Via
ACCESSWIRE
Quantum BioPharma to Present at Global Growth and Investment Conference Presented by ArcStone Securities and Invesments and Kingswood US
September 25, 2024
Via
ACCESSWIRE
Quantum Biopharma Receives Nasdaq Notification of Regaining Compliance with Nasdaq's Minimum Bid Price Requirement and Completes Debt Settlements
September 06, 2024
Via
ACCESSWIRE
Why Recursion Pharmaceuticals Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
↗
September 03, 2024
Via
Benzinga
Quantum BioPharma Ltd. (QNTM) Announces Key Milestones; Price Target $12.80
August 30, 2024
Via
ACCESSWIRE
Quantum Biopharma Announces Celly Nutrition Launches unbuzzd(TM) Grab-and-Go Stick Packs on Amazon.com so you can "own NOW and what’s NEXT"
August 30, 2024
Via
ACCESSWIRE
Why Affirm Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
↗
August 29, 2024
Via
Benzinga
Why Greenland Technologies Shares Are Trading Higher By Around 40%; Here Are 20 Stocks Moving Premarket
↗
August 16, 2024
Via
Benzinga
InvestorNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Announces Completion of Name Change, Begins Trading Under New Symbol
August 15, 2024
Via
Investor Brand Network
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >